Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Torben Mourits-Andersen"'
Autor:
Hans E. Johnsen, Lene M. Knudsen, Anne K. Mylin, Peter Gimsing, Henrik Gregersen, Niels Abildgaard, Niels Frost Andersen, Torben Plesner, Annette Vangsted, Torben Mourits-Andersen
Publikováno v:
Hematology Reports, Vol 1, Iss 2, Pp e11-e11 (2009)
The impact of chemotherapy resistant B cells in multiple myeloma (MM) needs to be evaluated by in vivo targeted therapy. Here we report the conclusions from a phase II randomized, placebo controlled trial adding fludarabine to the induction with cycl
Externí odkaz:
https://doaj.org/article/907fa9c7ca9a4fb19ec79b759507505c
Autor:
Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen, Mads Emil Bjørn, Christen Lykkegaard Andersen, Ole Weis Bjerrum, Nana Brochmann, Dustin Andersen Patel, Lise Mette Rahbek Gjerdrum, Daniel El Fassi, Torben A. Kruse, Thomas Stauffer Larsen, Hans Torben Mourits-Andersen, Claus Henrik Nielsen, Christina Ellervik, Niels Pallisgaard, Mads Thomassen, Lasse Kjær, Vibe Skov, Hans Carl Hasselbalch
Publikováno v:
Haematologica, Vol 105, Iss 9 (2020)
We report the final 2-year end-of-study results from the first clinical trial investigating combination treatment with ruxolitinib and low-dose pegylated interferon-α2 (PEG-IFNα2). The study included 32 patients with polycythemia vera and 18 with p
Externí odkaz:
https://doaj.org/article/bd7ece2e9ba54e0fb08e184f782b03a1
Autor:
R. Coleman Lindsley, Thomas Kielsgaard Kristensen, Mette Brabrand, Mads Thomassen, Charles Laurore, Jesper Stentoft, Christina Ellervik, Ann Mullally, Donna Neuberg, Lukas Frans Ocias, Daniel El Fassi, Karin de Stricker, William Duke, Anwesha Nag, Christopher J. Gibson, Marianne Tang Severinsen, Torben A Kruse, Lillian Werner, Torben Mourits-Andersen, Mikael Frederiksen, Trine Alma Knudsen, Thomas Stauffer Larsen, Aaron R. Thorner, Ulrik Malthe Overgaard, Dennis Lund Hansen, Bruce M. Wollison, Vibe Skov, Lasse Kjær, Joern Starklint, Kristen E. Stevenson, Ole Weis Bjerrum, Hans Carl Hasselbalch
Publikováno v:
Knudsen, T A, Skov, V, Stevenson, K E, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, El Fassi, D, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U, Frederiksen, M, Kristensen, T, Kruse, T, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses ', Blood Advances, vol. 6, no. 7, pp. 2107-2119 . https://doi.org/10.1182/bloodadvances.2021004856
Knudsen, T A, Skov, V, Stevenson, K E, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, El Fassi, D, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U M, Frederiksen, M, Kristensen, T K, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D S, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic Profiling of a Randomized Trial of Interferon-α versus Hydroxyurea in MPN Reveals Mutation-Specific Responses ', Blood advances, vol. 6, no. 7, pp. 2107–2119 . https://doi.org/10.1182/bloodadvances.2021004856
Knudsen, T A, Skov, V, Stevenson, K, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, Fassi, D E, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U M, Frederiksen, M, Kristensen, T K, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D S, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic profiling of a randomized trial of interferon-a vs hydroxyurea in MPN reveals mutation-specific responses ', Blood advances, vol. 6, no. 7, pp. 2107-2119 . https://doi.org/10.1182/bloodadvances.2021004856
Knudsen, T A, Skov, V, Stevenson, K, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, Fassi, D E, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U M, Frederiksen, M, Kristensen, T K, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D S, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic profiling of a randomized trial of interferon-a vs hydroxyurea in MPN reveals mutation-specific responses ', Blood Advances, vol. 6, no. 7, pp. 2107-2119 . https://doi.org/10.1182/bloodadvances.2021004856
Knudsen, T A, Skov, V, Stevenson, K E, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, El Fassi, D, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U M, Frederiksen, M, Kristensen, T K, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D S, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic Profiling of a Randomized Trial of Interferon-α versus Hydroxyurea in MPN Reveals Mutation-Specific Responses ', Blood advances, vol. 6, no. 7, pp. 2107–2119 . https://doi.org/10.1182/bloodadvances.2021004856
Knudsen, T A, Skov, V, Stevenson, K, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, Fassi, D E, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U M, Frederiksen, M, Kristensen, T K, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D S, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic profiling of a randomized trial of interferon-a vs hydroxyurea in MPN reveals mutation-specific responses ', Blood advances, vol. 6, no. 7, pp. 2107-2119 . https://doi.org/10.1182/bloodadvances.2021004856
Knudsen, T A, Skov, V, Stevenson, K, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, Fassi, D E, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U M, Frederiksen, M, Kristensen, T K, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D S, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic profiling of a randomized trial of interferon-a vs hydroxyurea in MPN reveals mutation-specific responses ', Blood Advances, vol. 6, no. 7, pp. 2107-2119 . https://doi.org/10.1182/bloodadvances.2021004856
Although somatic mutations influence the pathogenesis, phenotype, and outcome of myeloproliferative neoplasms (MPNs), little is known about their impact on molecular response to cytoreductive treatment. We performed targeted next-generation sequencin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a8b3349a821d5426c8d40af43b1de45
https://findresearcher.sdu.dk:8443/ws/files/201081075/Open_Access_Version.pdf
https://findresearcher.sdu.dk:8443/ws/files/201081075/Open_Access_Version.pdf
Autor:
Vibe Skov, Anders Lindholm Sørensen, Ole Weis Bjerrum, Christen Lykkegaard Andersen, Mads Thomassen, Christina Ellervik, Niels Pallisgaard, Mads Emil Bjørn, Thomas Stauffer Larsen, Nana Brochmann, Stine Ulrik Mikkelsen, Hans Carl Hasselbalch, Lasse Kjær, Torben A Kruse, Dustin Andersen Patel, Lise Mette Rahbek Gjerdrum, Claus Henrik Nielsen, Hans Torben Mourits-Andersen, Trine Alma Knudsen, Daniel El Fassi
Publikováno v:
Sorensen, A L, Mikkelsen, S U, Knudsen, T A, Bjorn, M E, Andersen, C L, Bjerrum, O W, Brochmann, N, Patel, D A, Gjerdrum, L M R, El Fassi, D, Kruse, T A, Larsen, T S, Mourits-Andersen, H T, Nielsen, C H, Ellervik, C, Pallisgaard, N, Thomassen, M, Kjaer, L, Skov, V & Hasselbach, H C 2020, ' Ruxolitinib and interferon-alpha 2 combination therapy for patients with polycythemia vera or myelofibrosis : a phase II study ', Haematologica, vol. 105, no. 9, pp. 2262-2272 . https://doi.org/10.3324/haematol.2019.235648
Haematologica
Sørensen, A L, Mikkelsen, S U, Knudsen, T A, Bjørn, M E, Andersen, C L, Bjerrum, O W, Brochmann, N, Patel, D A, Gjerdrum, L M R, El Fassi, D, Kruse, T A, Larsen, T S, Mourits-Andersen, H T, Nielsen, C H, Ellervik, C, Pallisgaard, N, Thomassen, M, Kjær, L, Skov, V & Hasselbalch, H C 2020, ' Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis : a phase II study ', Haematologica, vol. 105, no. 9, pp. 2262-2272 . https://doi.org/10.3324/haematol.2019.235648
Haematologica
Sørensen, A L, Mikkelsen, S U, Knudsen, T A, Bjørn, M E, Andersen, C L, Bjerrum, O W, Brochmann, N, Patel, D A, Gjerdrum, L M R, El Fassi, D, Kruse, T A, Larsen, T S, Mourits-Andersen, H T, Nielsen, C H, Ellervik, C, Pallisgaard, N, Thomassen, M, Kjær, L, Skov, V & Hasselbalch, H C 2020, ' Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis : a phase II study ', Haematologica, vol. 105, no. 9, pp. 2262-2272 . https://doi.org/10.3324/haematol.2019.235648
We report the final 2-year end-of-study results from the first clinical trial investigating combination treatment with ruxolitinib and low-dose pegylated interferon-alpha 2 (PEG-IFN alpha 2). The study included 32 patients with polycythemia vera and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2a2689350d3b831d68196ec37176bd6
https://doi.org/10.3324/haematol.2019.235648
https://doi.org/10.3324/haematol.2019.235648
Autor:
Margrethe Langer Bro, Peter Vuust, Elisabeth Wreford Andersen, Christoffer Johansen, Peter de Nully Brown, Jeppe Gram, Niels Abildgaard, Bodil Himmelstrup, Torben Mourits-Andersen, Francesco d'Amore, Lisbeth Enggaard
Publikováno v:
Bro, M L, Johansen, C, Vuust, P, Enggaard, L, Himmelstrup, B, Mourits-Andersen, T, Brown, P, d'Amore, F, Andersen, E A W, Abildgaard, N & Gram, J 2019, ' Effects of live music during chemotherapy in lymphoma patients : a randomized, controlled, multi-center trial ', Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol. 27, no. 10, pp. 3887-3896 . https://doi.org/10.1007/s00520-019-04666-8
Bro, M L, Johansen, C, Vuust, P, Enggaard, L, Himmelstrup, B, Mourits-Andersen, T, Brown, P, d'Amore, F, Andersen, E A W, Abildgaard, N & Gram, J 2019, ' Effects of live music during chemotherapy in lymphoma patients : a randomized, controlled, multi-center trial ', Supportive Care in Cancer, vol. 27, no. 10, pp. 3887-3896 . https://doi.org/10.1007/s00520-019-04666-8
Bro, M L, Johansen, C, Vuust, P, Enggaard, L, Himmelstrup, B, Mourits-Andersen, T, Brown, P, d’Amore, F, Andersen, E A W, Abildgaard, N & Gram, J 2019, ' Effects of live music during chemotherapy in lymphoma patients : a randomized, controlled, multi-center trial ', Supportive Care in Cancer, vol. 27, no. 10, pp. 3887-3896 . https://doi.org/10.1007/s00520-019-04666-8
Bro, M L, Johansen, C, Vuust, P, Enggaard, L, Himmelstrup, B, Mourits-Andersen, T, Brown, P, d'Amore, F, Andersen, E A W, Abildgaard, N & Gram, J 2019, ' Effects of live music during chemotherapy in lymphoma patients : a randomized, controlled, multi-center trial ', Supportive Care in Cancer, vol. 27, no. 10, pp. 3887-3896 . https://doi.org/10.1007/s00520-019-04666-8
Bro, M L, Johansen, C, Vuust, P, Enggaard, L, Himmelstrup, B, Mourits-Andersen, T, Brown, P, d’Amore, F, Andersen, E A W, Abildgaard, N & Gram, J 2019, ' Effects of live music during chemotherapy in lymphoma patients : a randomized, controlled, multi-center trial ', Supportive Care in Cancer, vol. 27, no. 10, pp. 3887-3896 . https://doi.org/10.1007/s00520-019-04666-8
PURPOSE: Chemotherapy is associated with both somatic and psychological side effects. Music might ease these problems. Several randomized controlled trials have investigated the effect of music, but the results are inconclusive. We aimed to examine w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::335bf9140fa56843ffd8f0f638d41774
https://pure.au.dk/portal/da/publications/effects-of-live-music-during-chemotherapy-in-lymphoma-patients(27116482-7307-4a5b-b0dd-02be10a979be).html
https://pure.au.dk/portal/da/publications/effects-of-live-music-during-chemotherapy-in-lymphoma-patients(27116482-7307-4a5b-b0dd-02be10a979be).html
Autor:
Mads Thomassen, Jesper Stentoft, Hans Carl Hasselbalch, Thomas Stauffer Larsen, Ole Weis Bjerrum, Marianne Tang Severinsen, Mette Brabrand, Vibe Skov, Lukas Frans Ocias, Thomas Kielsgaard Kristensen, Torben Mourits-Andersen, Ulrik Malthe Overgaard, Mikael Frederiksen, Trine Alma Knudsen, Dennis Lund Hansen, Torben A Kruse, Lasse Kjær, Peter Møller, Daniel El Fassi, Jørn Starklint, Karin de Stricker
Publikováno v:
Knudsen, T A, Hansen, D L, Ocias, L F, Bjerrum, O W, Brabrand, M, El Fassi, D, Frederiksen, M, Kjaer, L, Kristensen, T K, Kruse, T A, Mourits-Andersen, T, Moller, P, Overgaard, U M, Severinsen, M T, Skov, V, Stentoft, J, Starklint, J, de Stricker, K, Thomassen, M, Larsen, T S & Hasselbalch, H C 2018, ' Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial-a Randomized Controlled Phase III Clinical Trial ', Blood, vol. 132, no. 1 . https://doi.org/10.1182/blood-2018-99-111255
Knudsen, T A, Hansen, D L, Ocias, L F, Bjerrum, O W, Brabrand, M, El Fassi, D, Frederiksen, M, Kjær, L, Kristensen, T K, Kruse, T A, Mourits-Andersen, T, Møller, P, Overgaard, U M, Severinsen, M T, Skov, V, Stentoft, J, Starklint, J, de Stricker, K, Thomassen, M, Larsen, T S & Hasselbalch, H C 2018, ' Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera : Preliminary Results from the Three-Year Analysis of the Daliah Trial-a Randomized Controlled Phase III Clinical Trial ', Blood, vol. 132, no. Suppl 1, pp. 580 . https://doi.org/10.1182/blood-2018-99-111255
Knudsen, T A, Hansen, D L, Ocias, L F, Bjerrum, O W, Brabrand, M, El Fassi, D, Frederiksen, M, Kjær, L, Kristensen, T K, Kruse, T A, Mourits-Andersen, T, Møller, P, Overgaard, U M, Severinsen, M T, Skov, V, Stentoft, J, Starklint, J, de Stricker, K, Thomassen, M, Larsen, T S & Hasselbalch, H C 2018, ' Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera : Preliminary Results from the Three-Year Analysis of the Daliah Trial-a Randomized Controlled Phase III Clinical Trial ', Blood, vol. 132, no. Suppl 1, pp. 580 . https://doi.org/10.1182/blood-2018-99-111255
Background Recombinant Interferon Alpha-2a (r-IFNα) is a potent immunomodulating agent, which has been used off-label for the treatment of polycythemia vera (PV) for more than three decades and has been demonstrated to induce high rates of clinical,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd40781d5cd616e581043ece0f569001
https://portal.findresearcher.sdu.dk/da/publications/e3179d20-b94b-4c83-9ed2-31301298e4e6
https://portal.findresearcher.sdu.dk/da/publications/e3179d20-b94b-4c83-9ed2-31301298e4e6
Autor:
Margrethe Langer, Bro, Christoffer, Johansen, Peter, Vuust, Lisbeth, Enggaard, Bodil, Himmelstrup, Torben, Mourits-Andersen, Peter, Brown, Francesco, d'Amore, Elisabeth Anne Wreford, Andersen, Niels, Abildgaard, Jeppe, Gram
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 27(10)
Chemotherapy is associated with both somatic and psychological side effects. Music might ease these problems. Several randomized controlled trials have investigated the effect of music, but the results are inconclusive. We aimed to examine whether li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::480b0f5f5cdfebfaab58026bcc7e1d91
https://pubmed.ncbi.nlm.nih.gov/30762141
https://pubmed.ncbi.nlm.nih.gov/30762141
Autor:
Mads Thomassen, Christen Lykkegaard Andersen, Torben A Kruse, Trine Alma Knudsen, Hans Torben Mourits-Andersen, Mads Emil Bjørn, Daniel El Fassi, Hans Carl Hasselbalch, Lasse Kjær, Stine Ulrik Mikkelsen, Anders Lindholm Sørensen, Claus Henrik Nielsen, Niels Pallisgaard, Ole Weis Bjerrum, Vibe Skov, Thomas Stauffer Larsen, Nana Brochmann
Publikováno v:
Mikkelsen, S U, Kjær, L, Bjørn, M E, Knudsen, T A, Sørensen, A L, Andersen, C B L, Bjerrum, O W, Brochmann, N, Fassi, D E, Kruse, T A, Larsen, T S, Mourits-Andersen, H T, Nielsen, C H, Pallisgaard, N, Thomassen, M, Skov, V & Hasselbalch, H C 2018, ' Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosis ', Cancer Medicine, vol. 7, no. 8, pp. 3571-3581 . https://doi.org/10.1002/cam4.1619
Mikkelsen, S U, Kjaer, L, Bjørn, M E, Knudsen, T A, Sørensen, A L, Andersen, C B L, Bjerrum, O W, Brochmann, N, Fassi, D E, Kruse, T A, Larsen, T S, Mourits-Andersen, H T, Nielsen, C H, Pallisgaard, N, Thomassen, M, Skov, V & Hasselbalch, H C 2018, ' Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosis ', Cancer Medicine, vol. 7, no. 8, pp. 3571-3581 . https://doi.org/10.1002/cam4.1619
Cancer Medicine
Mikkelsen, S U, Kjaer, L, Bjørn, M E, Knudsen, T A, Sørensen, A L, Andersen, C B L, Bjerrum, O W, Brochmann, N, Fassi, D E, Kruse, T A, Larsen, T S, Mourits-Andersen, H T, Nielsen, C H, Pallisgaard, N, Thomassen, M, Skov, V & Hasselbalch, H C 2018, ' Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosis ', Cancer Medicine, vol. 7, no. 8, pp. 3571-3581 . https://doi.org/10.1002/cam4.1619
Cancer Medicine
Interferon‐α2 reduces elevated blood cell counts and splenomegaly in patients with myeloproliferative neoplasms (MPN) and may restore polyclonal hematopoiesis. Its use is limited by inflammation‐mediated toxicity, leading to treatment discontinu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db0a6b917568f2df9af769040c6996bb
https://findresearcher.sdu.dk:8443/ws/files/142548000/Safety_and_efficacy_of_combination_therapy_of_interferon_2_and_ruxolitinib_in_polycythemia_vera_and_myelofibrosis.pdf
https://findresearcher.sdu.dk:8443/ws/files/142548000/Safety_and_efficacy_of_combination_therapy_of_interferon_2_and_ruxolitinib_in_polycythemia_vera_and_myelofibrosis.pdf
Autor:
Christina Ellervik, A. Lindholm Sørensen, M. Tang Severinsen, Deepti Manjari Patel, Mette Brabrand, Vibe Skov, U. Malthe Overgaard, Mads Thomassen, O. Kruse, Hans Torben Mourits-Andersen, L. Frans Ocias, T. Alma Knudsen, H. Carl Hasselbalch, T. Stauffer Larsen, Peter Møller, Jørn Starklint, Morten Frederiksen, K. de Stricker, D. Lund Hansen, T. Kielsgaard Kristensen, O. Weis Bjerrum, Laura Kofoed Kjær, D. el Fassi, Jesper Stentoft
Publikováno v:
HemaSphere. 3:990-991
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4ec2ee494043e15f26a68dda71928f9
https://doi.org/10.1097/01.hs9.0000567320.93768.1b
https://doi.org/10.1097/01.hs9.0000567320.93768.1b
Autor:
A. Lindholm Sørensen, Vibe Skov, M. Tang Severinsen, T. Kielsgaard, K. de Stricker, Ulrik Malthe Overgaard, Trine Alma Knudsen, D. el Fassi, L. Frans Ocias, Peter Møller, Hans Torben Mourits-Andersen, O. Weis Bjerrum, Jørn Starklint, Torben A Kruse, Morten Frederiksen, T. Stauffer Larsen, D. Lund Hansen, Laura Kofoed Kjær, Christina Ellervik, Mette Brabrand, D. Andersen Patel, Jesper Stentoft, Hans Carl Hasselbalch, Mads Thomassen
Publikováno v:
HemaSphere. 3:741-742
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::171817c8edd6c841a7c8d32abf8a745d
https://doi.org/10.1097/01.hs9.0000564684.14072.fb
https://doi.org/10.1097/01.hs9.0000564684.14072.fb